DK0579833T3 - Ethanolaminderivater med anti-pollakisuria-virkning - Google Patents
Ethanolaminderivater med anti-pollakisuria-virkningInfo
- Publication number
- DK0579833T3 DK0579833T3 DK92908496.0T DK92908496T DK0579833T3 DK 0579833 T3 DK0579833 T3 DK 0579833T3 DK 92908496 T DK92908496 T DK 92908496T DK 0579833 T3 DK0579833 T3 DK 0579833T3
- Authority
- DK
- Denmark
- Prior art keywords
- hydrogen
- lower alkyl
- halogen
- hydroxy
- pollakisuria
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
- C07C255/59—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/04—Drugs for disorders of the urinary system for urolithiasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/32—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB919107827A GB9107827D0 (en) | 1991-04-12 | 1991-04-12 | New ethanolamine derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0579833T3 true DK0579833T3 (da) | 1997-09-15 |
Family
ID=10693176
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK92908496.0T DK0579833T3 (da) | 1991-04-12 | 1992-04-10 | Ethanolaminderivater med anti-pollakisuria-virkning |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0579833B1 (da) |
JP (1) | JP3158436B2 (da) |
AT (1) | ATE157080T1 (da) |
DE (1) | DE69221721D1 (da) |
DK (1) | DK0579833T3 (da) |
GB (1) | GB9107827D0 (da) |
WO (1) | WO1992018461A1 (da) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5578638A (en) * | 1993-11-05 | 1996-11-26 | American Cyanamid Company | Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists |
US5563171A (en) * | 1993-11-05 | 1996-10-08 | American Cyanamid Company | Treatment of glaucoma and ocular hypertension with β3-adrenergic agonists |
US6197993B1 (en) | 1996-07-02 | 2001-03-06 | Ono Pharmaceutical Co., Ltd. | Naphthyloxyacetic acid derivatives and a pharmaceutical composition comprising them as an active ingredient |
EP0845451A4 (en) * | 1995-07-26 | 1999-10-13 | Ono Pharmaceutical Co | NAPHTHYLOXYACETIC ACID DERIVATIVES AND MEDICINAL PRODUCTS INTEGRATING THESE DERIVATIVES AS ACTIVE INGREDIENTS |
US6075040A (en) | 1996-09-05 | 2000-06-13 | Eli Lilly And Company | Selective β3 adrenergic agonists |
ZA967892B (en) * | 1995-09-21 | 1998-03-18 | Lilly Co Eli | Selective β3 adrenergic agonists. |
KR100483635B1 (ko) * | 1995-10-26 | 2005-12-21 | 미쯔비시 도꾜 세이야꾸 가부시끼가이샤 | β3작동약으로서유용한페닐에탄올아민화합물,그의제법및그의제조에서의중간체 |
TW375604B (en) * | 1996-02-19 | 1999-12-01 | Kissei Pharmaceutical | 3,4-di-substituting phenyl-ethanolamine-tetrahydronaphthyl carboxylic amide derivatives |
JP3708624B2 (ja) * | 1996-03-27 | 2005-10-19 | キッセイ薬品工業株式会社 | 3,4−ジ置換フェニルエタノールアミノテトラリンカルボン酸誘導体 |
SG55296A1 (en) * | 1996-04-12 | 1998-12-21 | Kissei Pharmaceutical | Phenylethalolaminotetralincarboxamide derivatives |
KR100786315B1 (ko) * | 1996-04-12 | 2008-03-14 | 깃세이 야쿠힌 고교 가부시키가이샤 | 페닐에탄올아미노테트랄린카르복실산아미드유도체 |
CA2263659A1 (en) * | 1996-08-19 | 1998-02-26 | Kissei Pharmaceutical Co., Ltd. | Preventive/remedy for frequent urination and urinary incontinence |
ES2171839T3 (es) | 1996-09-05 | 2002-09-16 | Lilly Co Eli | Analogos de carbazol como agonistas adrenergicos selectivos de beta3. |
AUPO565997A0 (en) * | 1997-03-17 | 1997-04-10 | Fujisawa Pharmaceutical Co., Ltd. | Propanolamine derivatives |
CO5011072A1 (es) | 1997-12-05 | 2001-02-28 | Lilly Co Eli | Etanolaminas pirazinil substituidas como agfonistas de los receptores |
GB9913083D0 (en) | 1999-06-04 | 1999-08-04 | Novartis Ag | Organic compounds |
US6699338B2 (en) | 1999-04-08 | 2004-03-02 | Jfe Steel Corporation | Method of manufacturing corrosion resistant steel materials |
RU2004130455A (ru) * | 2002-03-14 | 2006-02-10 | Фудзисава Фармасьютикал Ко.,Лтд. (Jp) Фудзисава Фармасьютикал Ко.,Лтд. (Jp) | Производные аминоспиртов |
ZA200503510B (en) | 2002-11-07 | 2006-12-27 | Yamanouchi Pharma Co Ltd | Remedy for overactive bladder comprising acetic acid anilide derivative as the active ingredient |
CN101220118B (zh) * | 2007-01-12 | 2010-08-11 | 远东新世纪股份有限公司 | 改质共聚物及以其改质的鞘层材料及芯鞘型复合纤维 |
CA2794849A1 (en) * | 2010-04-08 | 2011-10-13 | Medicinova, Inc. | Methods and compositions for the treatment of irritable bowel syndrome |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL79323A (en) * | 1985-07-10 | 1990-03-19 | Sanofi Sa | Phenylethanolaminotetralines,their preparation and pharmaceutical compositions containing them |
US4927955A (en) * | 1987-08-12 | 1990-05-22 | Sanofi | Process for the O-alkylation of N-(hydroxy)aralkylphenylethanolamines |
EP0303545B1 (fr) * | 1987-08-12 | 1992-06-17 | Elf Sanofi | Procédé pour la préparation de phényléthanolaminotétralines |
FR2643076B1 (fr) * | 1989-02-14 | 1991-06-21 | Midy Spa | Carboxyalkyl-ethers de la 2-amino-7-hydroxytetraline |
ATE144139T1 (de) * | 1989-06-13 | 1996-11-15 | Sanofi Sa | Verwendung von phenylethanolaminen zur herstellung von medikamenten gegen augenleiden |
-
1991
- 1991-04-12 GB GB919107827A patent/GB9107827D0/en active Pending
-
1992
- 1992-04-10 DK DK92908496.0T patent/DK0579833T3/da active
- 1992-04-10 AT AT92908496T patent/ATE157080T1/de active
- 1992-04-10 DE DE69221721T patent/DE69221721D1/de not_active Expired - Lifetime
- 1992-04-10 EP EP92908496A patent/EP0579833B1/en not_active Expired - Lifetime
- 1992-04-10 WO PCT/JP1992/000449 patent/WO1992018461A1/en active IP Right Grant
- 1992-04-10 JP JP50807592A patent/JP3158436B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP3158436B2 (ja) | 2001-04-23 |
EP0579833A1 (en) | 1994-01-26 |
WO1992018461A1 (en) | 1992-10-29 |
JPH06506676A (ja) | 1994-07-28 |
GB9107827D0 (en) | 1991-05-29 |
EP0579833B1 (en) | 1997-08-20 |
DE69221721D1 (de) | 1997-09-25 |
ATE157080T1 (de) | 1997-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0579833T3 (da) | Ethanolaminderivater med anti-pollakisuria-virkning | |
GR3032311T3 (en) | Stilbene derivatives and pharmaceutical compositions containing them | |
TR200200579T2 (tr) | Amino-tirazolpiridin türevleri. | |
MX9204008A (es) | Derivados de metilen-oxindol y proceso para su preparacion. | |
MX9504349A (es) | Derivados de aroilpiperidina. | |
IL104567A (en) | Ethanolamine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same | |
WO1999024022A3 (en) | Isoquinoline derivatives for treating disorders associated with 5ht7 receptors | |
IE901883L (en) | Antispasmodic agents | |
DE69330601D1 (de) | Serotoninergische ergolin derivate | |
DK0648202T3 (da) | Substituerede (arylalkylaminobenzyl)aminopropanamidderivater, fremstilling deraf og anvendelse som anti-epileptiske, neurobeskyttende og antidepressive midler | |
NO973340L (no) | Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av fedme | |
NO973242L (no) | Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av idiopatisk eller fysiologisk gynekomasti | |
DE69203445D1 (de) | Neuro-schützende Mittel. | |
ATE228359T1 (de) | Hemmung der leukotrienbiosynthese mittels harnstoffderivaten | |
FI941850A0 (fi) | Uusi yhdiste, joka on leustroduksiini H, sen valmistus ja terapeuttinen käyttö |